Good morning :)
Place Order
Add to Watchlist

Vaishali Pharma Ltd

VAISHALI Share Price

12.360.57% (+0.07)

VAISHALI Share Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹132 cr, stock is ranked 2,688
High RiskStock is 4.02x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹132 cr, stock is ranked 2,688
High RiskStock is 4.02x as volatile as Nifty

VAISHALI Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
323.153.09
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.006.390.53%

VAISHALI Analyst Ratings & Forecast

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

VAISHALI Company Profile

Vaishali Pharma Limited is a pharmaceutical company engaged in dealing in pharmaceutical formulations, active pharmaceutical ingredient (APIs), surgical products, veterinary supplements, and herbal and nutraceutical products

VAISHALI Similar Stocks (Peers)

Compare with peers 
PE Ratio
44.71
1Y Return
14.01%
Buy Reco %
88.24
PE Ratio
29.86
1Y Return
5.19%
Buy Reco %
72.73
PE Ratio
65.86
1Y Return
26.18%
Buy Reco %
68.00
PE Ratio
17.93
1Y Return
2.08%
Buy Reco %
45.16
PE Ratio
52.09
1Y Return
13.24%
Buy Reco %
80.00
Compare with Peers

VAISHALI Forecasts

Price

Revenue

Earnings

VAISHALI

Income

Balance Sheet

Cash Flow

VAISHALI Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 2.76%, vs industry avg of 9.04%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.04% to 0.02%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 0%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue69.8964.9069.4277.0762.2655.5877.6171.8988.31102.27
Raw Materialssubtract62.0753.9460.6167.7850.9945.8663.5457.1071.7599.84
Power & Fuel Costsubtract0.000.000.000.000.000.000.000.000.00
Employee Costsubtract1.561.592.042.131.271.191.361.301.40
Selling & Administrative Expensessubtract0.002.382.972.152.621.944.064.283.44
Operating & Other expensessubtract2.532.59-0.650.964.312.13-0.03-2.398.03
Depreciation/Amortizationsubtract0.370.280.250.270.440.430.460.500.510.50
Interest & Other Itemssubtract3.373.102.852.662.562.632.492.262.271.54
Taxes & Other Itemssubtract0.030.330.550.420.050.361.702.240.21-0.02
EPS-0.000.010.010.000.000.100.380.630.070.04
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

VAISHALI Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2018

Annual Report Unavailable

Investor Presentation

Jun 1PDF
Feb 26PDF
FY 2019

Annual Report Unavailable

FY 2020

Annual Report Unavailable

Investor Presentation

May 28PDF
FY 2021

Annual Report Pending

Investor Presentation

Aug 6PDF
 

VAISHALI Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Vaishali Pharma Ltd189.273.09
Sun Pharmaceutical Industries Ltd44.716.380.76%
Cipla Ltd29.864.590.85%
Torrent Pharmaceuticals Ltd65.8615.910.87%

VAISHALI Stock Price Comparison

Compare VAISHALI with any stock or ETF
Compare VAISHALI with any stock or ETF
VAISHALI
Loading...

VAISHALI Shareholdings

VAISHALI Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

VAISHALI Institutional Holdings Trend

Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 4.97%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

VAISHALI Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding26.32%0.00%0.00%0.00%73.68%

Jun 2024

Jul 2024

Sep 2024

Dec 2024

VAISHALI Shareholding History

MarMayJunJulSepDec '240.00%0.02%0.00%0.00%0.00%0.00%

VAISHALI Insider Trades & Bulk Stock Deals

Loading...

smallcases containing VAISHALI stock

Looks like this stock is not in any smallcase yet.

VAISHALI Events

VAISHALI Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

VAISHALI has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

VAISHALI Dividends

Hmm, looks like data is unavailable here. Please come back after some time

VAISHALI Stock News & Opinions

Earnings
Vaishali Pharma standalone net profit declines 31.75% in the December 2024 quarter

Net profit of Vaishali Pharma declined 31.75% to Rs 1.44 crore in the quarter ended December 2024 as against Rs 2.11 crore during the previous quarter ended December 2023. Sales rose 0.04% to Rs 27.91 crore in the quarter ended December 2024 as against Rs 27.90 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales27.9127.90 0 OPM %4.8410.54 - PBDT2.042.98 -32 PBT1.922.86 -33 NP1.442.11 -32 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Vaishali Pharma announces board meeting date

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 6 February 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Vaishali Pharma to conduct board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Vaishali Pharma standalone net profit rises 15.88% in the September 2024 quarter

Net profit of Vaishali Pharma rose 15.88% to Rs 1.97 crore in the quarter ended September 2024 as against Rs 1.70 crore during the previous quarter ended September 2023. Sales rose 65.39% to Rs 20.79 crore in the quarter ended September 2024 as against Rs 12.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales20.7912.57 65 OPM %11.6421.08 - PBDT2.752.48 11 PBT2.632.36 11 NP1.971.70 16 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Vaishali Pharma to hold board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Vaishali Pharma schedules board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 10 October 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Vaishali Pharma to conduct board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 3 October 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Vaishali Pharma to hold board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 August 2024.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Vaishali Pharma to convene AGM

Vaishali Pharma announced that the 17th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Vaishali Pharma standalone net profit rises 6.92% in the June 2024 quarter

Net profit of Vaishali Pharma rose 6.92% to Rs 1.70 crore in the quarter ended June 2024 as against Rs 1.59 crore during the previous quarter ended June 2023. Sales rose 34.72% to Rs 18.08 crore in the quarter ended June 2024 as against Rs 13.42 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.0813.42 35 OPM %13.0017.21 - PBDT2.392.24 7 PBT2.272.12 7 NP1.701.59 7 Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Vaishali Pharma Ltd (VAISHALI) today?

    The share price of VAISHALI as on 21st March 2025 is ₹12.36. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Vaishali Pharma Ltd (VAISHALI) share?

    The past returns of Vaishali Pharma Ltd (VAISHALI) share are
    • Past 1 week: -0.08%
    • Past 1 month: -22.70%
    • Past 3 months: -32.72%
    • Past 6 months: -36.50%
    • Past 1 year: -11.78%
    • Past 3 years: 94.49%
    • Past 5 years: 170.46%

  3. What are the peers or stocks similar to Vaishali Pharma Ltd (VAISHALI)?
  4. What is the market cap of Vaishali Pharma Ltd (VAISHALI) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vaishali Pharma Ltd (VAISHALI) is ₹132.49 Cr as of 21st March 2025.

  5. What is the 52 week high and low of Vaishali Pharma Ltd (VAISHALI) share?

    The 52-week high of Vaishali Pharma Ltd (VAISHALI) is ₹24.91 and the 52-week low is ₹11.65.

  6. What is the PE and PB ratio of Vaishali Pharma Ltd (VAISHALI) stock?

    The P/E (price-to-earnings) ratio of Vaishali Pharma Ltd (VAISHALI) is 189.27. The P/B (price-to-book) ratio is 3.09.

  7. Which sector does Vaishali Pharma Ltd (VAISHALI) belong to?

    Vaishali Pharma Ltd (VAISHALI) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Vaishali Pharma Ltd (VAISHALI) shares?

    You can directly buy Vaishali Pharma Ltd (VAISHALI) shares on Tickertape. Simply sign up, connect your demat account and place your order.